Viewing Study NCT05552261


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2026-05-12 @ 1:58 PM
Study NCT ID: NCT05552261
Status: COMPLETED
Last Update Posted: 2025-11-28
First Post: 2022-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
Sponsor: Dompé Farmaceutici S.p.A
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurotrophic Keratitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage 1 NK View
None OXERVATE® View
None Cenegermin View
None NK View
None DEFENDO View
None NGF0120 (original DEFENDO study) View
None NGF0122 (DEFENDO long-term follow-up study) View